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doi:10.1016/j.ejvs.2011.03.023Abstract Background: Guidelines and protocols assist in the clinical management of
patients, helping to utilise available resources efficiently, however, there is limited documen-
ted guidance on surveillance of patients following open arterial surgery. The frequency of clin-
ical follow up, Doppler ultrasound measurements and radiological imaging should all be
justified. Here we review the available literature to offer an evidenced based approach to
postoperative care.
Method: An electronic search was made of Medline and Embase databases through September
2009 revealing over 2300 studies in the initial searches. Following title and abstract screening,
the relevant medical literature concerning post-operative surveillance of open vascular proce-
dures was reviewed (300 papers). 42 papers were included in this review. Surveillance recom-
mendations were constructed from the evidence presented.
Results and conclusion: Detailed anatomical imaging is available for the technical assessment in
the majority of patients’ postoperative management; however there is little Level 1 evidence to
guide modality or timing. Grades B and C recommendations form the majority of surveillance
recommendations. Clinical review remains the mainstay of surveillance following open periph-
eral arterial surgery. Duplex scanning is the imaging modality of choice when indicated in most
instances. Minimal data exists to quantify quality of life or intervention efficacy.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.education questions on this
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ty for Vascular Surgery. PublisheIntroduction
Vascular surgery commonly involves complex operations on
patients with significant anaesthetic risks. Such operations
are often designed with the fundamental ideal of improving
blood flow. Technical operative success and graft patency
have become the targets of many interventions. This
requires measurement and assessment of the grafts ed by Elsevier Ltd. All rights reserved.
60 T.R.A. Lane et al.surveillance, but it also allows assessment of surgical
results and intervention efficacy.
Appropriate surveillance should aim to positively influ-
ence patients’ quality of life, improve vascular service effi-
ciency and assist with service rationing; with best clinical
result the over-riding goal.
Previous work in pre-malignant diseases and cancer has
shown that without clear information, surveillance can be
depressing and confusing1 but the impact of a reassuring
review cannot be overlooked.2
Surveillance must have a clear therapeutic benefit,
especially as with improved life expectancy, revision surgery
and intervention may become a more frequent occurrence.
Evidence based medicine is the process of systematically
reviewing, appraising and using clinical research findings to
aid delivery of optimum clinical care to patients.3 These
studies are utilized for best practice recommendations,
graded as shown in Table 1.4
Evidence based guidelines to support post-operative
surveillance programmes are conspicuous by their absence in
vascular surgery. The aim of this review is provide a summary
of theavailable literature tohelp guide suchprogrammes, and
highlight the need for further research where appropriate.
This review divides interventions into three sections:
 Carotid and Subclavian Intervention
 Aorto-iliac Intervention
 Infra-inguinal InterventionMethod
An electronic search was made of Medline and Embase
databases through to September 2009 and relevant English
language medical literature concerning post-operative
surveillance of open vascular procedures reviewed. Specific
terms used included surveillance, follow-up, post-opera-
tive, vascular, surgery, open, and operation name which
yielded over 2300 studies. Three researchers title-screened
and abstract-screened the results of the keyword searches.
Exclusion criteria included papers dealing solely with
endovascular techniques, non-English language, studies
without clear follow-up information detailing timescales
and procedure. Single case reports were also excluded. 300
papers were then critically assessed in full by the three
researchers, with 42 papers and their level of evidenceTable 1 Grades of recommendation and levels of evidence an
Evidence-based Medicine4).
Grades of Recommendation Level of Evidence
A 1a
A 1b
A 1c
B 2a
B 2b
B 2c
B 3a
B 3b
C 4
D 5included in the final review. Guidelines, criteria and
recommendations were assessed by all four authors. The
studies are summarised in Tables 2e5. The methodology is
expressed as a flow diagram below Fig. 1.Carotid intervention (Table 2)
Carotid endarterectomy
7 studies concerning carotid endarterectomy were identi-
fied with a published follow-up up protocol and surveillance
assessment, and one meta-analysis. A case series of 192
patients by Golledge et al. (Level 4 evidence) showed that
duplex ultrasonography within 1 week of carotid endar-
terectomy (CEA) identifies both gross abnormalities, such
as >50% residual stenosis (n Z 4), pseudoaneurysm, intra-
luminal thrombus as well as minor residual (25%e50%)
stenosis (n Z 25) and small internal carotid artery dimen-
sions, which are good predictors of >50% restenosis at
6 months, which was found in 21 of the 192 cases assessed.5
The same group showed that delayed restenosis is not
associated with an increased risk of ipsilateral stroke or
transient ischaemic attack (TIA) (3% vs. 6%, p > 0.5),6 and
Naylor et al. have shown no benefit from either clinical or
imaging follow-up for the ispilateral side.7 Mattos et al.8
presented a non-significant 10 year stroke-free survival
rate difference of 94.4% in carotids with restenosis
following CEA versus 90.6% in non-restenosed vessels (Level
4 evidence). However, a meta-analysis by Frerick et al.
failed to find evidence in favour of routine surveillance,9
and a cost utility analysis by the same group showed no
benefit in terms of quality of life improvements from
surveillance.10
Naylor et al. have previously shown that after CEA the
risk of ipsilateral stroke is 1.8% per annum,7 and of
contralateral stroke 1e1.4%.11,12 Roth et al.’s case series of
242 carotid endarterectomy cases, surveillance has shown
some benefits to monitoring contralateral disease progres-
sion after CEA, with an intervention rate of 5.9% for
contralateral disease,12 CEA may influence contralateral
disease progression. Ballotta et al.13 showed 25% (148 of
599) of mild (30e49%) or moderate (50e69%) stenoses
progressed by one grouping over 3 years, with moderate
stenoses progressing quickest (18.5 versus 29.8 months).
Ricco et al.14 showed a rate of recurrent ipsilateral stenosis
(>50%) of 3.8% at 5 years, in a series of 605 patients (573d research. (Adapted with permission from Oxford Centre of
Description
Systematic review of RCT
Individual RCT
All or None Case Series
Systematic review of cohort studies
Individual cohort studies
Outcomes research
Systematic review of case-control studies
Individual case-control study
Case series, poor quality cohort and case-control studies
Expert opinion without explicit critical appraisal
Table 2 Summary table of carotid intervention studies referenced.
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
Carotid Endarterectomy
Golledge et al.
(1997)5
Prospective
Case Series
(Level 4)
192 24 Duplex
ultrasound
Ipsilateral
stenosis
> 50 stenosis
at 6 months
13% > 50%
stenosis
at 6 months
Duplex scanning
at 1 week is good
predictor of
restenosis > 50%
at 6 months
Golledge et al.
(1997)6
Prospective
Case Series
(Level 4)
305 36 Duplex
ultrasound
Ipsilateral
stenosis
or new
neurological
symptoms
CVA or TIA
after CEA
10% ipsilateral
symptoms
at 6 months
8% contralateral
symptoms
at 9 months
No benefit in long
term duplex
surveillance
after CEA
Naylor et al.
(1996)7
Prospective
Case Series
(Level 4)
260 240 Duplex
ultrasound
Angiography
Ipsilateral
neurological
symptoms
8% ispilateral
neurological
symptoms
(4.8% CVA,
3.2% TIA)
Cumulative
freedom from
occlusion or
severe
recurrent
stenosis
(>70%) 87%
at 5 years
and 78% at
10 years
Neither clinical
nor surveillance
imaging could
have prevented
any of the strokes
observed during
follow-up
Naylor et al.
(1995)11
Prospective
Case Series
(Level 4)
260 48 Duplex
ultrasound
Angiography
Ipsilateral
neurological
symptoms
Progression of
contralateral
ICA stenosis
>70 stenosis 7% (10)
progressed
to >70%
stenosis
Of those 3
became
symptomatic
No benefit in
surveillance of
contralateral
internal carotid
artery
(continued on next page)
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Table 2 (continued)
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
Mattos et al.
(1993)8
Retrospective
Case Series
(Level 4)
409 42 Duplex
ultrasound
Ipsilateral
Stenosis
> or Z 50%
stenosis
Severe
recurrence
Z 80%e99%
stenosis
10.8% recurrence
2.1% severe
recurrence
25.6% of
recurrent
stenoses
symptomatic
5 year CVA
free Z 94.4%
with recurrence;
94.2%
without
Recurrent carotid
artery stenosis
occurs early after
CEA, is typically
benign, and
remains stable
over a prolonged
follow-up period.
Importance of
routine surveillance
questioned and
more conservative
approach suggested
Roth et al.
(1999)12
Prospective
Case Series
(Level 4)
242 27.4 Duplex
ultrasound
Ipsilateral
stenosis
> 50%
stenosis
2.7% asymptomatic
recurrence
12% contralateral
>50% stenosis
progression
5.9% additional
intervention rate
overall
1.6% incidence of
disabling stroke,
contralateral
Surveillance yield
was low. Progression
of existing
contralateral
disease most
common.
Duplex scanning
at 1e2 year
intervals adequate
in minimal
contralateral disease
with precise
original repair
Ballotta et al.
(2007)13
Prospective
Case Series
(Level 4)
599 120 Duplex
ultrasound
Progression of
contralateral
stenosis
or late
neurologic
events
Progression
to higher
stenosis
category
(mild
30e49%,
moderate
50e69%,
severe
70e99%,
occluded)
25.2% disease
progression
overall (at mean
follow up of 48 months)
34.3% mild to
moderate
progression
47.9% moderate
to severe
progression
3.2% contralateral
neurologic events
(0.7% CVA,
2.5% TIA)
Duplex ultrasound
surveillance
supported, suggested
at 6 monthly
intervals, in patients
with moderate or
severe disease
62
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Ricco et al.
(2003)14
Prospective
Case Series
(Level 4)
605 24 Duplex
ultrasound
Ispilateral and
contralateral
Stenosis
Residual
stenosis Z >49%
stenosis on
1 week scan
Recurrent
stenosis Z >49%
stenosis after
normal 1 week
scan
3.8% ipsilateral
recurrence
at 5 years
22.9% contralateral
progression from >50%
to >70% at 1 year,
30.1% at 3 years
98.3% CVA free at 3 years
94.5% CVA free at 6 years
Duplex ultrasound at
1 year is unnecessary
unless initial scan
shows residual
stenosis.
Duplex ultrasound
at one year is
beneficial for patients
with contralateral
stenosis >50% at
time of initial
intervention
Transposition of Subclavian Artery
Law et al.
(1995)16
Retrospective
Case Series
(Level 4)
9 44 Duplex
ultrasound
Overall
patency rate
Symptom
free survival
Overall patency
rate
Symptom free
survival
100% 5 year patency
85.5% 5 year symptom-
free survival
Transposition results
in long-term patency
Cina` et al.
(2002)17
Prospective
Cohort
Study And
Systematic
Review of
Case Series
(Level 3a)
23 25 Duplex
ultrasound
Overall
patency
Overall patency 100% 2 year patency
87% 2 year survival
Transposition is safe
with long term
patency
Carotid-Subclavian Bypass Grafting
AbuRahma et al.
(2000)18
Prospective
Case Series
(Level 4)
51 120 Duplex
ultrasound
Overall patency
Symptom-Free
Survival
Overall patency
Symptom-Free
Survival
92% 10 year
primary
patency
95% 10 year
secondary
patency
88% 10 year
free from
symptoms
Carotid-subclavian
bypass grafting
with PTFE grafts
are safe, effective
and durable.
Law et al.
(1995)16
Retrospective
Case Series
(Level 4)
51 44 Duplex
ultrasound
Overall
patency
rate
Symptom free
survival
Overall patency
rate
Symptom free
survival
95.2% 5 year
patency
PTFE graft
(n Z 25)
83.9% 5 year
patency
Dacron graft
(n Z 15)
64.8% 5 year
patency
vein graft
(n Z 11)
Transposition results
in long term patency,
synthetic grafts have
reduced patency
and autologous
grafts relatively
poor patency
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64 T.R.A. Lane et al.patch technique, 32 eversion). Contralateral stenosis >50%
increased significantly to > 70% in 22.9% of cases at 1 year,
and 30.1% at 3 years.
These studies12e14 suggest that monitoring of contra-
lateral disease is required at yearly intervals, if asymp-
tomatic stenosis treatment is planned, however this
remains controversial in the era of statin therapy.15
Recommendation
No level 1, 2 or 3 evidence exists to support surveillance or
to suggest surveillance prevents further symptoms.
Level 4 evidence supports carotid duplex within 1 week
to predict a restenosis of >50% at 6 months (Grade C).5
Duplex ultrasonography at one year post-operatively is
appropriate if there is a residual stenosis or contralateral
stenosis >50% at 1 week post-operatively (Level 4 evidence
e Grade C) and asymptomatic treatment is planned.13 If
asymptomatic treatment is not planned, there is no
evidence to support surveillance.11
Subclavian artery stenosis
3 studies were found discussing subclavian artery stenosis
treatment surveillance.
Transposition of subclavian artery
Subclavian artery transposition patency rates range from
98% to 100%.16,17 A systematic review of 58 publications
(n Z 511) by Cina` et al.17 produced a 98% cumulative
patency rate at 5 years. Law et al.16 found one asymp-
tomatic occlusion at >13 years (n Z 9) (Level 4 evidence).
Recommendation
Level 3a evidence suggests surveillance is unwarranted due
to high patency rates (Grade B).
Carotid-subclavian bypass grafting
Carotid-Subclavian Bypass Grafting utilizes three types of
conduit: Polytetrafluoroethylene (PTFE), Dacron and vein
grafts, with differing patency rates. In contrast to infra-
inguinal repair, PTFE is the best conduit with a 5-year
patency rate of 95.2%16 followed by Dacron (84%) and
autologous saphenous vein (64.8%). All patency failures
seen in Law et al.’s series occurred between 9 and 15
months post-operatively, irrespective of conduit.16 AbuR-
ahma et al.18 provided 10-year follow-up data of PTFE
bypass grafting using 6 monthly clinical review and duplex
ultrasound scanning with a primary patency rate of 92%,
and secondary patency rate of 95%, with the first fall in
patency at 3 years.
Recommendation
Surveillance is unwarranted for PTFE grafting due to
excellent primary patency rates. Surveillance of Dacron
and vein grafts has not been shown to improve patency
rates with re-intervention driven by symptom recurrence
(Level 4 evidence e Grade C).Aorto-iliac intervention (Table 3)
15 studies and 1 consensus document were identified
regarding surveillance in aorto-iliac intervention.Aorto-iliac and aorto-bifemoral bypass
The high flow rates of aorto-iliac and aorto-bifemoral
bypass grafts appear to be protective against deterioration
with studies showing good primary patency rates (aorto-
iliac e 88.5% at 5 years19 and aorto-bifemoral e 93% at
3 years20). However iliac disease is now more commonly
treated with stents, reserving bypass surgery for more
extensive disease. Thus current aorto-iliac bypasses may
have a greater risk of occlusion if the disease is more
extensive. There have been no studies concerning duplex or
clinical surveillance of aorto-iliac or aorto-bifemoral bypass
for patency or aneurysmal dilatation.
Recommendations
Level 4 evidence suggests surveillance is unnecessary due
to good primary patency rates (Grade C).
Ilio-femoral bypass
Ilio-femoral bypass is a relatively rare procedure utilised in
circumstances where an aorto-femoral or a femoro-femoral
crossover graft is not appropriate.21Melliere et al.22 reviewed
144 bypasses (over 20 years) obtaining a primary patency rate
of 66% at 8 years with annual duplex surveillance. Carsten
et al.21 reported a secondary patency rate of 97.5% and 93.3%
at 1 and 5 years respectively (40 patients over 9 years). 5-year
primary and secondary graft patency rates of 40 procedures
by Nazzal et al.23 were 61.3% and 80.5%.
Crossover ileofemoral bypass gives primary and
secondary patency rates at one year of 94% and 100%, and
at 5 years of 76.7% and 95% respectively.24
Recommendations
Level 4 evidence supports annual clinical review, ABPI and
colour duplex imaging for Ilio-femoral bypass; clinical
review and Doppler measurements for crossover ilio-femoral
bypass due to falling primary patency rates (Grade C).
Axillo-femoral bypass
There is minimal literature on follow-up of axillo-femoral
bypass for aorto-iliac disease. The procedure has two
separate patient groups e one with occlusive disease and
one with infection of a previous graft, often for aneurysmal
disease. However, due to the health of patients and the
length of the bypass, both are at higher risk of complication
and occlusion.25 Due to improved surgical technique and
antimicrobial treatment 3 year primary and secondary
patency rates of 80.2% and 87.4% have been achieved26
with 5 year patency rates of 66%.27
Recommendations
Level 4 evidence suggests that with similar primary and
secondary patency rates there is no benefit from surveil-
lance (Grade C).
Femoro-femoral cross-over bypass
Previously, femoro-femoral bypass (FFB) cross-over grafts
have obtained inferior patency rates compared to AFB
techniques,28 despite more recent studies showing a 92% 6
year cumulative patency rate.29 The technique offers a less
invasive procedure for appropriate patients (either limited
disease or unfit for AFB techniques).
Table 3 Summary table of aorto-iliac intervention studies referenced.
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
Aorto-Iliac & Aortobifemoral Bypass
Onohara et al.
(2000)19
Retrospective
Case Series
(Level 4)
38 60 Not
defined
Overall
survival
Patency
Overall survival
Patency
82.8% overall su ival
(axillo-bifemora nd
aortobifemoral oled)
88.5% 5 year pr ary
patency
96.5% 5 year
secondary pate y
Comparison of axillo-bifemoral
and aortobifemoral bypass.
Both survival and primary
patency superior in
aortobifemoral bypass
Kashyap et al.
(2008)20
Retrospective
Case Series
(Level 4)
75 36 Overall
survival
Patency
Overall survival
Patency
80% 3 year over l
survival
93% 3 year prim y
patency
97% 3 year prim y
patency
Reasonable patency rates
achieved
Ilio-femoral bypass
Melliere et al.
(2004)22
Prospective
Case Series
(Level 4)
144 120 Duplex
ultrasound
Primary
patency
Primary patency 66% 8 year prim y
patency
Comparison between
aortounifemoral bypass,
ileofemoral bypass, crossover
bypass and iliac
endarterectomy. Iliac
endarterectomy should
be first choice
Carsten et al.
(2008)21
Retrospective
Case Series
(Level 4)
40 60 Not
defined
Patency
Limb
salvage
Patency
Limb salvage
97.5% 1 year
secondary pate y
93.3% 5 year
secondary pate y
85.1% 1 year lim
salvage rate
79.1% 5 year lim
salvage rate
Excellent technical and
functional outcomes
achieved, giving an
acceptable and safe
alternative to
aortobifemoral or
femoro-femoral
crossover graft
(continued on next page)
Su
rve
illa
n
ce
a
fte
r
O
p
e
n
P
e
rip
h
e
ra
l
A
rte
ria
l
Su
rge
ry
65rv
l a
po
im
nc
al
ar
ar
ar
nc
nc
b
b
Table 3 (continued)
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
Nazzal et al.
(1998)23
Retrospective
Case Series
(Level 4)
40 28 Not
defined
Survival
Primary
Patency
Secondary
Patency
Survival
Primary Patency
Secondary
Patency
73.3% 5 year survival
61.3% primary
patency
80.5% secondary
patency
15.8% required
revascularisation
Comparison between
extra-anatomic
femoro-femoral
crossover bypass
grafting and anatomic
ileofemoral bypass
grafting.
No significant
difference in long term
results, both giving
acceptable patency
Defraigne et al.
(1999)24
Retrospective
Case Series
(Level 4)
36 72 Duplex
ultrasound,
ABPI and
mutiplane
angiography
Survival
Primary
Patency
Secondary
Patency
Limb
salvage
rate
Survival
Primary Patency
Secondary
Patency
Limb salvage
rate
97.3% 1 year survival
68.5% 5 year survival
94% 1 year primary
patency
76.7% 5 year primary
patency
100% 1 year secondary
patency
95% 5 year secondary
patency
100% 1 year limb
salvage rate
87% 3 year limb
salvage rate
Long term primary and
secondary patency rates
are satisfactory, with low
operative mortality
Axillo-femoral bypass
Lehnert et al.
(1993)25
Retrospective
Case Series
(Level 4)
21 24 Not
defined
Survival
Primary
Patency
Limb
Salvage
Rate
Survival
Primary Patency
Limb Salvage
Rate
80% 1 year survival
55% 3 year survival
40% 5 year survival
62% 1 year primary
patency
51% 3 year primary
patency
40% 5 year primary
patency
89% 1 year limb
salvage rate
63% 3 year limb
salvage rate
63% 5 year limb
salvage rate
Extra-anatomic reconstruction
in patients with graft infection
can be performed with low
operative mortality
66
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Sharp et al.
(1994)26
Retrospective
Case Series
(Level 4)
20 36 Not
defined
Primary
Patency
Secondary
Patency
Primary Patency
Secondary
Patency
3.7% rioperative
mor ty
80.2 year primary
pate y
87.4 year
seco ary patency
Axillo-femoral bypass provided
a satisfactory long term outcome
Hertzer et al.
(2007)27
Retrospective
Case Series
(Level 4)
91 40 Not
defined
Survival
Patency
Survival
Patency
12% erative
mor ty
68% ear survival
38% ear survival
87% ear patency
74% ear patency
66% ear patency
Comparison of 1 surgeons
experience of all open
procedures.
High mortality for extra-
anatomic bypass largely
due to bias of patient
selection. However direct
reconstruction offers
better long term
patency rates
Femoro-femoral Crossover bypass
Piotrowski et al.
(1988)28
Prospective
Case Series
(Level 4)
96 Not
defined
Biplane
arteriorgraphy
and ’non-
invasive
methods’
Primary
Patency
Primary Patency 100% BF 1 year primary
pate y
100% BF 3 year primary
pate y
72% F 5 year primary
pate y
56% 1 year primary
pate y
56% 3 year primary
pate y
56% 5 year primary
pate y
72% 1 year primary
pate y
53% 3 year primary
pate y
35% 5 year primary
pate y
Aortic Bifemoral byass (ABF) is
the preferred technique for
exensive iliac disease especially
in the context of superficial
femoral artery disease
Ng et al.
(1992)29
Retrospective
Case Series
(Level 4)
231 Not
defined
Not
defined
Cumulative
Patency
Cumulative
Patency
75% ear IF cumulative
pate y
92% ear FF cumulative
pate y
Significantly improved patency
at 6 years and significantly shorter
hospital stay for femoro-femoral
(FF) bypass compared to ileofemoral
bypass (IF)
(continued on next page)
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Table 3 (continued)
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Re nce Conclusion
Hinchliffe et al.
(2003)30
Prospective
Case Series
(level 4)
231 22 Computerised
tomography
Cumulative
patency
Cumulative
patency
91% r cumu e
pate
83% r cumu e
pate
Femoro-femoral bypass provides
good medium and long-term
patency rates in the context of
aneurysmal disease
Ricco
(1992)32
Randomised
Prospective
Cohort Study
(level 2b)
143 22 Duplex
ultrasound
and digital
subtraction
angiography
Primary
Patency
Secondary
Patency
Primary Patency
Secondary
Patency
52% r FF pr y
pate
89% r IF pri y
pate
93.6 ear FF s ndary
pate
92.9 ear IF s ndary
pate
Direct revascularisations
(ileofemoral e IF) are preferable
in the young patient compared
to crossover revascularisation
(femoro-femoral e FF)
Stone et al.
(2006)33
Retrospective
Case Series
(Level 4)
108 40 Duplex
ultrasound
Primary
Patency
Primary Patency 86% r prima
pate
78% r prima
pate
62% r prima
pate
98% r prima
pate
93% r prima
pate
93% r prima
pate
Duplex ultrasound surveillance
D’Addio et al.
(2005)34
Retrospective
Case Series
(Level 4)
54 47 Duplex
ultrasound
Primary
Patency
Secondary
Patency
Primary Patency
Secondary
Patency
97% r prima
pate
93% r prima
pate
76% r prima
pate
100% ar seco ry
pate
95% r secon y
pate
90% r secon y
pate
Femoro-femoral crossover bypass
has excellent 1, 3 and 5 year
patency rates when performed
with femoral popliteal vein
68
T.R
.A
.
La
n
e
e
t
a
l.curre
3 yea
ncy
5 yea
ncy
4 yea
ncy
4 yea
ncy
% 4 y
ncy
% 4 y
ncy
1 yea
ncy
3 yea
ncy
5 yea
ncy
1 yea
ncy
3 yea
ncy
5 yea
ncy
1 yea
ncy
3 yea
ncy
5 yea
ncy
1 ye
ncy
3 yea
ncy
5 yea
ncylativ
lativ
imar
mar
eco
eco
ry
ry
ry
ry
ry
ry
ry
ry
ry
nda
dar
dar
Table 4 Summary table of infra-inguinal intervention studies referenced.
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
Infrainguinal bypass - Autologous Vein
Davies et al.
(1994)35
Prospective
Case Series
(Level 4)
88 9.1 Duplex
ultrasound
and digital
subtraction
angiography
(DSA)
Grafts ’at risk’
or failed
Predictive ability
of Ankle Brachial
Pressure Index
(ABPI), Duplex
ultrasound
50% stenosis
in graft
or change
in distal
run off
with narrowing
>50% or
change in
inflow
with vessel
narrowing >50%
25% ’at risk’ or failed
grafts confirmed by DSA
51% ’at risk’ grafts
identified by ABPI
91% ’at risk’ grafts
identified by duplex
ultrasound with
velocity variables
73% ’at risk’ grafts
identified by
impedence
The most sensitive mode
of non-invasive graft
surveillance is colour
Duplex providing the
assessment involves
both a measurement
of the velocity ratio
and the absolute velocity.
Golledge et al.
(1996)36
Systemic
Review
(Level 1a)
6257 40e49 Duplex
Ultrasound
Surveillance
Group Only
Mortality, graft
occlusion, presence
of stenoses
Mortality, graft
occlusion,
presence
of stenoses
Total number of
deaths, occluded
grafts and occlusions
after 30 days
were significantly
greater for the
non-surveillance group
Perioperative occlusion
rates were not
significantly different.
The numbers of
amputations were
not significantly
different between
the two groups
Comparison of surveillance
and non-surveillance
studies. The patency of
infra-inguinal vein grafts
is improved by
surveillance, no
improvement can be
demonstrated with
respect to limb
salvage rates.
(continued on next page)
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Table 4 (continued)
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recu ence Conclusion
Ihlberg et al.
(1998)37
Prospective
Controlled
Randomised Trial
(level 1b)
152 12 Duplex
Ultrasound
Surveillance
Group Only
Primary Patency
Assisted Primary
Patency
Secondary
Patency
Primary
Patency
Assisted
Primary
Patency
Secondary
Patency
68% 1 ar primary
paten in
Non-su eillance
group
58% 1 ar primary
paten in
Survei ce Group
74% 1 ar assisted
prima atency
in Non rveillance
group
65% 1 ar assisted
prima atency in
Survei ce group
84% 1 ar secondary
paten in
Non-su eillance group
71% 1 ar secondary
paten in
Survei ce group
This study failed to show
any beneficial effect of
duplex scanning in a
surveillance program.
The main difference in
outcome appeared
during the first post-
operative month before
the commencement of
the surveillance program.
Ihlberg et al.
(1999)38
Prospective
Controlled
Randomised Trial
(Level 1b)
362 12 Duplex
Ultrasound
Surveillance
Group Only
Assisted Primary
Patency
Secondary Patency
Limb Salvage Rate
Assisted
Primary
Patency
Secondary
Patency
Limb Salvage
Rate
77% 1 ar assisted
prima atency in
Non-su eillance
group
77% 1 ar assisted
prima atency in
Survei ce group
87% 1 ar secondary
paten in
Non-su eillance group
85% 1 ar secondary
paten in Surveillance
group
94% 1 ar limb salvage
rate in on-surveillance
group
93% 1 ar limb
salvag ate in
Survei ce group
Intensive surveillance
with duplex scanning
did not improve the
results of any outcome
criteria examined
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Mofidi et al.
(2007)40
Prospective Cohort
Study (Level 2b)
364 23 Duplex
Ultrasound
for first
12 months
Primary Patency
Stenosis
Progression
Critical Z >350 PSV
Intermediate Z
250e350 PSV
Mild Z 200e250 PSV
Low-risk Z <200 PSV
10% 40 month primary
patency of critical
grafts
84% 40 month primary
patency of
intermediate grafts
56% 40 month
progression of
intermediate grafts
90% 40 month primary
patency of mildly
stenosed grafts
38% 40 month
progression of mildly
stenosed grafts
82% 40 month
primary patency
of low-risk grafts
93% 40 month limb
salvage rate of low-risk
grafts
For grafts
without any flow
abnormality at 6 weeks,
the yield from
continuing with
duplex surveillance
is likely to be low
and probably little
better than what is
achievable by simple
clinical follow-up.
Lundell et al.
(1995)41
Prospective
Controlled
Randomised
Trial (Level 1b)
156 36 Duplex
Ultrasound
Surveillance
Group Only
Assisted Primary
Cumulative Patency
Secondary Patency
Assisted Primary
Cumulative
Patency
Secondary
Patency
78% 3 year assisted
primary patency
in surveilled vein
grafts
53% 3 year assisted
primary patency
in non-surveilled
vein grafts
82% 3 year
secondary patency
in surveilled vein grafts
56% 3 year
secondary patency
in non-surveilled
vein grafts
57% 1 year assisted
primary patency
in surveilled
prosthetic grafts
50% 1 year assisted
primary patency in
non-surveilled
prosthetic grafts
Intensive surveillance
identified failing vein
grafts leading to a
significantly higher
cumulative assisted
primary and secondary
patency compared
with cumulative
assisted primary and
secondary
patency after routine
follow-up examination.
The patency of
e-polytetrafluoroethylene
and composite grafts was
not influenced by
intensive surveillance.
(continued on next page)
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Table 4 (continued)
Study Study Type N Mean
Follow-up
(months)
Imaging
Technique
Outcome
Measure
Outcome
Definition
% Recurrence Conclusion
67% 1 year secondary
patency in surveilled
prosthetic grafts
54% 1 year secondary
patency in non-
surveilled prosthetic
grafts
Davies et al.
(2005)42
Prospective
Controlled
Randomised
Trial (Level 1b)
594 18 Duplex
Ultrasound
Surveillance
Group Only
Amputation Rate
Vascular Mortality
Rate
Primary Patency
7% Amputation Rate in
surveillance group
7% Amputation Rate in
non-surveillance group
3% Vascular Mortality in
surveillance group
4% Vascular Mortality
Rate in non-surveillance
group
69% primary patency in
surveillance group
67% primary patency in
non-surveillance group
Intensive surveillance
with duplex scanning
did not show any
additional benefit in
terms of limb salvage
rates for patients
undergoing vein bypass
graft operations, but it
did incur additional costs.
Fasih et al.
(2004)43
Prospective
Controlled
Trial (Level 1b)
106 36 Duplex
Ultrasound
Surveillance
Group Only
Graft Occlusion
Amputation Rate
69% 3 year occlusion
rate in non-surveillance
group
22% 3 year occlusion
rate in surveillance
group
38% 3 year amputation
rate in non-surveillance
group
2% 3 year amputation
rate in surveillance
group
Graft surveillance
helped to improve
patency of grafts by
identifying the
correctable lesions
Tinder et al.
(2008)44
Retrospective
Case Series
(Level 4)
353 48 Duplex
Ultrasound
Primary Patency
Assisted Primary
Patency
Secondary Patency
Normal
grafts Z PSV
<180 cm/s
Abnormal
grafts Z PSV
180e300 cm/s
46% 3 year primary
patency
80% 3 year assisted
primary patency
81% 3 year secondary
patency
The efficacy of duplex
surveillance after infra-
inguinal vein bypass
may be enhanced by
modifying testing
protocols based on
the initial duplex scan
results and other
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87% 3 year assisted
primary patency
normal grafts
68% 3 year assisted
primary patency
abnormal grafts
characteristics predictive
for stenosis development
Nguyen et al.
(2004)45
Retrospective
Case Series
(Level 4)
188 51 Duplex
Ultrasound
Primary Patency
Secondary Patency
60% 5 year popliteal
bypass revision primary
patency
42% 5 year tibial bypass
revision primary
patency
90% 5 year popliteal
bypass revision
secondary patency
76% 5 year tibial bypass
revision secondary
patency
Vein graft revisions offer
durable patency and limb
salvage rates after repair
of stenotic infra-inguinal
bypass grafts. Vigilant
ongoing surveillance is
essential, because 30.9%
of revised grafts
will develop additional
lesions that will
require repair.
Infrainguinal bypass e Prosthetic Graft
Dunlop et al.
(1996)46
Prospective
Cohort Study
(Level 2b)
69 36 Duplex
Ultrasound
Graft failure
Detection of
treatable
stenoses
Not defined 20% graft failure
10% detection rate
86% failed grafts
not identified by
surveillance
Surveillance appears
to be of limited benefit
in the maintenance of
patency of synthetic
infra-inguinal bypass
grafts.
Calligaro et al.
(2001)47
Retrospective
Case Series
(Level 4)
89 Not defined Duplex
ultrasound
The results support
the routine use
of DU as a part of a
graft surveillance
protocol for femorotibial,
but not femoropopliteal,
prosthetic graft
Brumberg et al.
(2007)48
Retrospective
Case Series
(Level 4)
130 17 Duplex
ultrasound
Cumulative
Patency
High grade
stenosis Z
PSV >300 cm/s
39% 3 year primary
patency
59% 3 year
secondary patency
Low graft flow was a
more common mode of
prosthetic bypass failure
than development of
duplex scan-detected
stenotic lesions during
follow-up. Early duplex
scanning may be more
important for characterizing
midgraft velocity and
related thrombotic potential
and selecting patients
for chronic anticoagulation.
(continued on next page)
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74 T.R.A. Lane et al.Initial EVAR technique utilized aorto-uniiliac prosthesis,
necessitating FFB. FFB for iatrogenic obstructive disease
has improved patency rates compared to naturally occurring
occlusive disease, although occlusion of the bypass graft is
associated with significant morbidity (20% mortality and 20%
amputation rate in non-infected occluded grafts).30
The Trans-Atlantic Inter-Society Consensus II (TASC II)31
recommendation for diffuse and long segment unilateral
iliac disease is open surgery. Ricco et al.32 produced primary
and secondary patency rates of 52%and 93%at 48monthswith
yearly clinical review, walking distance assessment and pre-
and post-exercise ABPI measurements (Level 2b evidence).
Stone et al.33 performed a retrospective review of 6
monthly duplex ultrasound surveillance on patency of FFB
grafts in 108 patients. Intervention was triggered when PSV
reached >300 cm/s, achieving patency rates of 95% at
1 year and 88% at 5 years (Level 4 evidence).
Recent work with femoro-popliteal deep vein grafts for
FFB (where prosthetic material is contra-indicated), these
conduits achieve good patency rates with 6 monthly duplex
surveillance (at 1, 3 and 5 years primary patency was 97%,
93% and 76%; secondary patency 100%, 95% and 90%).34
Recommendation
Level 2bevidence suggests yearly clinical follow-up,withpre-
and post-exercise ABPI measurements, duplex ultrasound
surveillance does not confer additional advantage (Grade B).Infrainguinal intervention (Table 4)
14 studies and 1 book chapter were identified concerning
surveillance of infrainguinal intervention.
Infrainguinal bypass grafting is a common index proce-
dure for vascular surgeons, but is associated with significant
technical difficulty. Long-term patency is the goal for all
procedures but may be unnecessary in some cases, and so
limb salvage rates are often utilised to more clearly delin-
eate results.
Autologous vein
‘At risk’ grafts have been defined as an ABPI fall of >0.2,
having a peak mean velocity (PMV) < 45 cm/s and exit
velocity/start velocity (V2/V1) of > 2.35
A systematic review of 6649 vein grafts by Golledge et
al.36 concluded the total number of deaths, occluded grafts
and the number of occlusions after 30 days were signifi-
cantly greater in those not undergoing surveillance.
However this surveillance did not improve the limb salvage
rate.
An analysis (Level 1a evidence) of Ihlberg et al.’s data37,38
showed clinical surveillance was better than duplex
surveillance in terms of primary and secondary patency
rates.39 Patients with no flow abnormality at 6 weeks had an
82% cumulative patency and 93% limb salvage rate at 40
months with 6 monthly clinical reviews with ABPIs (Level 2b
evidence).40
A randomised controlled trial (RCT) of 156 patients
showed that duplex scans every 3 months for 2 years, with
an additional scan at 3 years following femoropopliteal/
crural vein bypass surgery significantly improved assisted
primary cumulative and secondary patency rates at 3 years
Table 5 Summary of vascular surveillance review recommendations.
Procedure Surveillance Recommended (level of evidence)
Carotid Endarterectomy Ipsilateral duplex after 1 week (Grade C)
Contralateral duplex after 1 year (Grade C) if asymptomatic
treatment planned
Transposition of subclavian artery Clinical review at 6 weeks (Grade B)
Carotid-subclavian bypass If PTFE conduit e clinical review at 6 weeks (Grade C)
If autologous vein - clinical review and duplex every 6 months
(Grade C)
Aortoiliac bypass No evidence to support routine followup
Young patients (under 50) - clinical review and duplex annually
(Grade B)
Ilio-femoral bypass Clinical review, ABPI and duplex annually (Grade C)
Axillo-femoral bypass No evidence to support routine follow up (Grade C)
Femoro-femoral cross over bypass Annual clinical review, with pre and post-exercise ABPI (Grade B)
Femoro-distal bypass (vein) Routine post-operative duplex surveillance does not improve limb
salvage rate (Grade A).
Duplex at 6 weeks helps predict failing grafts (Grade B).
3 monthly clinical review with ABPI measurements for 1 year (Grade A).
Femoro-distal bypass (prosthetic) No evidence to support routine duplex or ABPI measurement (Grade A)
Surveillance after Open Peripheral Arterial Surgery 75(Level 1b evidence).41 However no benefit was found in
duplex surveillance, when compared to ABPI measurements
over 3 years, in terms of patency and limb salvage (Level 1b
evidence),37 or when compared to 3 monthly ABPI’s over
the first postoperative year (Level 1b evidence).38
The Vein Graft Surveillance Trial RCT of 594 patients who
underwent femoropopliteal or femorocrural vein bypass
showed no difference in primary patency, secondary
patency and most importantly, amputation rates between
duplex and clinical surveillance (Level 1b evidence).42
In a study of 106 femoropopliteal bypass grafts (vein 56,
PTFE 44, Dacron 6), successful angioplasty occurred in 22%
of patients undergoing duplex surveillance on 2 out of
3 intervals of 3, 6 and 12 months. A V2:V1 ratio of >4 (70%Infrainguinal
Infrainguinal
Included
lliac
lliac
Full
Full
Initial Electronic Searches
Vascular, Surveillance, Follow
individual
Title
Figure 1 Flow diagram of studies included.stenosis) indicated angioplasty. A significant reduction in
graft occlusion rates at 1 and 3 years with duplex surveil-
lance was shown. Graft occlusion was commoner in critical
ischaemia compared to claudication. Mortality rates were
similar at 2 years.43
There is some evidence that if duplex surveillance is used
it should be tailored to operative findings and patient
factors. Abnormal initial duplex testing indicating moderate
(PSV: 180e300 cm/s, V2:V1 ratio of 2e3.5) stenosis, non-
single segment saphenous vein conduit, warfarin drug
therapy, and redo bypass grafting are all characteristics of
duplex-detected stenoses leading to intervention and may
benefit from more frequent duplex surveillance.44
Following vein graft revision, on-going clinical and
duplex surveillance is recommended; as 30.9% will develop
additional lesions requiring treatment (Level 4 evidence).45
Prosthetic graft
Lundell et al.41 showed no benefit at one year after
3 monthly duplex scans following femoro-popliteal/crural
PTFE bypass surgery (Level 1b evidence). Dunlop et al.46
showed no benefit with 3 monthly ABPI measurements
and graft Duplex after 3 years (Level 2b evidence).
Duplex performed 3 monthly for 2 years then 6 monthly
of 33 prosthetic femoro-tibial bypasses had a sensitivity and
specificity of 88% and 89% at predicting an abnormal graft.47
Brumberg et al.48 recommended early duplex to detect low
flow (midgraft velocity  45 cm/s) which predicts grafts ‘at
risk’.
There is no evidence supporting routine duplex surveil-
lance of prosthetic femoro-distal bypass grafts.49
Recommendation
Despite conflicting reports, level 1a evidence does not
support the use of post-operative duplex scan surveillance
(Grade A).
Clinical deterioration and a drop in ABPI of >0.2 detects
failing infrainguinal vein bypasses (Level 1b e Grade A).
76 T.R.A. Lane et al.Duplex at 6 weeks helps predict which grafts are likely to
fail and hence may benefit from surveillance (Grade B).
Level 1b evidence does not support the use of duplex
imaging compared to clinical review and ABPI measure-
ments every 3 months in prosthetic bypass (Grade A).
Discussion
Many diseases, both malignant and non-malignant, now
have guidelines for surveillance, helping to maintain good
clinical care efficiently whilst maintaining the patient’s
quality of life. Vascular surgery should not differ and the
formation of structured follow up is overdue. The 4 key
aims of surveillance e improved quality of life, service
efficiency, service rationing and best clinical result; are
poorly served by the evidence currently available. Struc-
tured programmes with clear patient education are the goal
but extensive good quality clinical research is required to
reach it. Whilst some grade A recommendations can be
made, there are still plenty of grade C recommendations.
With endovascular advances, surveillance comparison with
open surgery would enable better evaluation of both
techniques. Endovascular procedures have high rates of
surveillance but controlled analyses of the benefits of such
programmes are rare.
A summary of recommendations is presented in Table 5.
This review is limited by the paucity of trials and the
inconsistency in reporting of follow-up and surveillance.
Studies that have reported long-term follow-up have
necessarily provided evidence spanning different genera-
tions of medical therapeutics, and may not be appropriate
in the age of statins and multiple antiplatelet agents. The
improvement of angiographic and angioplasty techniques
have also changed the applicability of previous studies.
The advent of high-quality duplex ultrasonography
should allow standardisation of reporting criteria and
subsequently improved evidence for and against surveil-
lance and intervention.
Conclusion
There is clearly a lack of high-level evidence for surveil-
lance in several areas of open vascular surgery. Surveillance
policies should be created and grouped using the type of
operation and the use of prosthetic material, as a basis for
individual management plans.
Much of the current evidence investigates whether
surveillance improves graft patency rates and amputation
rates. Is this the appropriate measure for patients who are
at high risk of morbidity from intervention to improve
falling patency, which may be asymptomatic. Studies into
patients’ quality of life are lacking and few studies have
performed a cost analysis into vascular surveillance. Serial
outpatient review of frail patients requiring hospital
transport that is unnecessary is a burden to both patient
and hospital staff, and resource inefficient.
Further work is needed for study guidelines to replace
anecdotal practice. Whilst randomised controlled trials
assessing surveillance are difficult to accomplish due to the
length of study required, the lack of existing evidence
provides a fertile ground for improvement. As has beenshown by the RCTs for infra-inguinal grafting such trials are
possible and provide vital evidence for appropriate service
planning and service economics.41,42 Multi-centre trials are
likely to be required for procedures performed infre-
quently, which would most benefit from standardised
surveillance plans.Funding
None.Conflict of Interest
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